Omthera Pharmaceuticals' Acquisition

Omthera Pharmaceuticals was acquired by AstraZeneca on May 28, 2013.

Omthera Pharmaceuticals is a specialty pharmaceuticals company focusing its efforts on the clinical development of new therapies for dyslipidemia. Omthera is dedicated to developing therapies for pati…

Articles about Omthera Pharmaceuticals' Acquisition: